Born just a week after India gained independence, Indoco Remedies has witnessed and been a part of the trials and triumphs of the country's pharma sector for the last seven decades. Now, as we gear up to celebrate the 71st anniversary of the day which marked the end of colonial rule in India, the company has grown steadily to become a well-known entity in the Indian pharma sector.
Goa's independence in 1961, ending Portuguese rule on the Gomantak heartland, proved to be a blessing to the company as well as it served to stabilise its operations. In 1963, when Suresh Kare, the founder's son took charge as the Managing Director, the company's annual turnover was around ₹ 3 lakhs and had 30 employees on payroll, a loss-making entity.
The turnaround
It was now up to the new leader to turn the company's fortunes and make it a profit-making venture. An uphill task in the business environment which existed in the country at that time. However, Suresh proved his mettle with hard work and business strategies that gradually put the company on the growth track. The government's decision to favour indigenous players over the MNCs who had dominated the industry since independence also spurred the growth trajectory of the company.
The passage of the Indian Patent Act in 1970, which brought in the regime of ‘Process Patents’, the export initiatives taken by the industry in 1990s, liberalisation of the economy in 1991, opened up new growth avenues for domestic players. Indoco, helmed by an able leader was able to capitalise on the opportunities and emerge as a significant entity in an expanding landscape.
Charting a success story
هذه القصة مأخوذة من طبعة August 1-15, 2017 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 1-15, 2017 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation